SARP is planning to establish in-house well equipped testing laboratories along with R & D and F&D centers supported by highly qualified, technical and skilled personnel. Besides, SARP has sufficient infrastructure to develop & obtain D.C.G.I approval for new
Fixed Dose Combinations (F.D.Cs) and has already got D.C.G.I approval for more than 50 new F.D.Cs to manufacture & market the products.